title: [Opportunistic infections in patients under highly concentrated antiretroviral therapy].
abstract: VARIABLE RESULTS: The restoration of immunological competence following Highly Active AntiRetroviral Therapy (HAART) has led to promising results concerning cytomegalovirus viremia, atypical mycobacterium infections, and survival in patients treated for non-Hodgkin's lymphomas. The beneficial effect of introducing antiproteases is less clear for other opportunistic infections such as tuberculosis and pyogenic infections.
  
  
  RESULTS
  In patients with a CD4 count above 240/mm3, it would appear possible to stop primary prophylaxis against Pneumocystis carinii and toxoplasmosis.
authors.affiliation: Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitié-Salpêtrière, Paris.
authors.forename: M
authors.initials: M
authors.lastname: Jouan
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000139:chemically induced*; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D004359:Drug Therapy, Combination; D006801:Humans; D007121:Immunocompetence / Q000187:drug effects; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000276:immunology; D012190:Retroviridae / Q000187:drug effects; D012192:Retroviridae Infections / Q000188:drug therapy
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents